placebo for 12 weeks

DRUG4 trials

Sponsors

Cellular Molecular Research Center, Tehran University of Medical Sciences, Wyeth is now a wholly owned subsidiary of Pfizer, MERCK SHARP & DOHME PERU S.R.L.,

Conditions

Rheumatoid ArthritisType 2 diabetes. Non-insulin-dependent diabetes mellitusmethamphetamine dependence. mental and behavioral disorders due to use of other stimulants, dependence syndrome

Phase 2

Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis

CompletedNCT00141830

Wyeth is now a wholly owned subsidiary of PfizerRheumatoid Arthritis

Start: 2005-08-31End: 2006-10-19Updated: 2020-09-29

Phase 3

The Study of Vitamin D Supplement Effect on Improvement of Glycemic Indexes in Type 2 Diabetics

Active, not recruitingIRCT201011185191N6

Cellular Molecular Research CenterType 2 diabetes. Non-insulin-dependent diabetes mellitus

Start: 2010-06-22Target: 60Updated: 2018-02-22

Slow-release Methylphenidate in the treatment of methamphetamine dependence

Active, not recruitingIRCT201202281556N38

Tehran University of Medical Sciencesmethamphetamine dependence. mental and behavioral disorders due to use of other stimulants, dependence syndrome

Start: 2012-03-15Target: 70Updated: 2018-02-22

Unknown Phase

A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE COADMINISTRATION OF EZETIMIBE / SIMVASTATIN AND PHENOFIBRATE IN PATIENTS WITH MIXED HYPERLIPIDEMIA

Active, not recruitingPER-087-04

MERCK SHARP & DOHME PERU S.R.L.,

Target: 20Updated: 2023-09-04

Related Papers

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.

2015-01-1531 citations